Corrigendum to: Intrathecal idursulfase-IT in patients with neuronopathic mucopolysaccharidosis II: Results from a phase 2/3 randomized study.

Muenzer, Joseph; Burton, Barbara K; Harmatz, Paul; Gutiérrez-Solana, Luis González; Ruiz-Garcia, Matilde; Jones, Simon A; Guffon, Nathalie; Inbar-Feigenberg, Michal; Bratkovic, Drago; Hale, Michael; Wu, Yuna; Yee, Karen S; Whiteman, David A H; Alexanderian, David.

Affiliation

Muenzer J; University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. Electronic address: muenzer@med.unc.edu.
Burton BK; Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University, Chicago, IL, USA.
Harmatz P; UCSF Benioff Children's Hospital Oakland, Oakland, CA, USA.
Gutiérrez-Solana LG; Infant Jesus Children's Hospital, Madrid, Spain.
Ruiz-Garcia M; National Institute of Pediatrics, Mexico City, Mexico.
Jones SA; St Mary's Hospital, Manchester University NHS Foundation Trust, University of Manchester, Manchester, UK.
Guffon N; Reference Center for Inherited Metabolic Diseases, Hospices Civils de Lyon, Lyon, France.
Inbar-Feigenberg M; University of Toronto, Toronto, ON, Canada; The Hospital for Sick Children, Toronto, ON, Canada.
Bratkovic D; Women's and Children's Hospital, North Adelaide, SA, Australia.
Hale M; Takeda Development Center Americas, Inc., Cambridge, MA, USA; Hale Scientific Statistics, LLC, Beaverton, OR, USA.
Wu Y; Takeda Development Center Americas, Inc., Lexington, MA, USA.
Yee KS; Takeda Development Center Americas, Inc., Cambridge, MA, USA.
Whiteman DAH; Takeda Development Center Americas, Inc., Lexington, MA, USA.
Alexanderian D; Takeda Development Center Americas, Inc., Lexington, MA, USA; Affinia Therapeutics, Inc., Waltham, MA, USA.

Mol Genet Metab ; 140(3): 107645, 2023 Nov.

Article in En | MEDLINE | ID: mdl-37541906

Full text: 1 Database: MEDLINE Type of study: Clinical_trials Language: En Year: 2023 Type: Article

Full text: 1 Database: MEDLINE Type of study: Clinical_trials Language: En Year: 2023 Type: Article